DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED

All News Dawnrays Pharmaceutical (Holdings) Limited

Equities

2348

KYG2687M1006

Delayed Hong Kong S.E. Other stock markets 01:38:07 09/05/2024 pm IST			5-day change	1st Jan Change
1.19 ^HKD	+0.85%		+1.71%	+13.33%

25/03	Dawnrays' 2023 Profit Falls 9% on Lower Revenue	MT
22/03	Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024	26/03	CI
Dawnrays' 2023 Profit Falls 9% on Lower Revenue	25/03	MT
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
Akeso Unit Buys 35% Stake in Biopharmaceutical Firm from Dawnrays; Akeso Shares Slide 3%	09/02	MT
Ex-dividend day for interim dividend	19/23/19	FA
Dawnrays Pharmaceutical Limited Declares Interim Dividend for the Year Ending December 31, 2023, Payable on October 5, 2023	25/23/25	CI
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2023	25/23/25	CI
Dawnrays Pharmaceutical Limited Announces the National Medical Products Administration Accepts the New Drug Application for Ebronucimab Injection	02/23/02	CI
Final dividend	30/23/30	FA
Dawnrays Pharmaceutical Limited Approves Final Dividend for the Year Ended 31 December 2022	25/23/25	CI
Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 13 June 2023	26/23/26	CI
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2022	26/23/26	CI
Dawnrays Pharmaceutical Unit to Provide $14.4 Million Loan to AD Pharmaceuticals	25/22/25	MT
Ex-dividend day for interim dividend	20/22/20	FA
Dawnrays Pharmaceutical Limited(SEHK:2348) dropped from S&P Global BMI Index	19/22/19	CI
Dawnrays Pharmaceutical Limited Announces Interim Semi-Annual Ordinary Dividend for the Six Months Ended 30 June 2022, Payable on 05 October 2022	26/22/26	CI
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2022	26/22/26	CI
Ex-dividend day for final dividend	31/22/31	FA
Dawnrays Pharmaceutical Limited Declares Final Dividend for the Year Ended December 31, 2021	27/22/27	CI
Dawnrays Pharmaceutical Limited Proposes to Declare Final Dividend for the Year Ended December 31, 2021	21/22/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Dawnrays Pharmaceutical (Holdings) Limited

Equities

2348

KYG2687M1006

All News

Filters